XTNT 10-Q: SEC filing
Xtant Medical Holdings
Filed with the SEC on · accession 0001493152-26-052000
XTNT filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. Xtant Medical Holdings filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data.
Summary of the filing
Xtant Medical Holdings filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data. The filing includes segment revenue breakdowns for orthobiologics, spinal implants, and license revenue, along with details on credit agreements and equity incentive plans.
Key details
✦ Ask GOAX AI about this filing — what it means for XTNT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for XTNT?
Click hereFrequently asked questions
What did XTNT file with the SEC on Nov 16, 2026?
XTNT filed a 10-Q (SEC filing). Xtant Medical Holdings filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data. The filing includes segment revenue breakdowns for orthobiologics, spinal implants, and license revenue, along with details on credit agreements and equity incentive plans.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other XTNT SEC filings
Get alerts when XTNT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days